Document is current
Any future updates will be listed below
-
Authors
Santyr, Brendan
Loh, Aaron
Germann, Jürgen
Boutet, Alexandre
Ajala, Afis
Qiu, Jianwei
Albuainain, Ghadh
Abbass, Mohamad
Madhavan, Radhika
Elias, Gavin
Vetkas, Artur
Chow, Clement
Sarica, Can
Munhoz, Renato
Ibrahim, George M.
Kalia, Suneil
Fasano, Alfonso
Lozano, Andres M.
-
Funding
Funding for this research was provided by:
Parkinson Canada
Michael J Fox Foundation (MJFF-008877)
National Institute of Neurological Disorders and Stroke of the National Institutes of Health (1R01NS133433-01)
European Joint Programme Neurodegenerative Disease Research
- License Information
-
More Information
Article History
Received: 21 December 2025
Accepted: 17 April 2026
First Online: 28 April 2026
Competing interests
: A.M.L. is the scientific director of Functional Neuromodulation Ltd. and a consultant for Medtronic, Abbott, Boston Scientific, and Insightec. AF received honoraria and/or research support from Abbott, AbbVie, Boston Scientific, Ceregate, Inbrain, and Medtronic. SKK received consulting fees from Medtronic. GMI received consulting and advisory fees from Medtronic, Livanova, and Synergia. A.B., R.M., and A.M.L. have intellectual property related to this paper.
